Thus, the documented tumor suppressive effect of BECN1 on breast cancer cells may be partly due to its capacity to interact with Class III PI3Ks or HER2 (Erb-b2 receptor tyrosine kinase 2)36. The gene discussed is ERBB2; the disease is breast cancer.